VKTX
Viking Therapeutics Inc
28.00$
+7.2%
vs. previous close
Closing price · As of: Nov 4, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Viking Therapeutics Inc (VKTX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/28/2026 | Current report (8-K) | Viking Therapeutics, Inc. (VKTX): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 09/28/2026 | Current report (8-K) | Viking Therapeutics, Inc. (VKTX): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits | View report ↗ |
| 09/25/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 09/25/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 09/23/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 09/23/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 09/22/2026 | Current report (8-K) | Viking Therapeutics, Inc. (VKTX): Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/29/2026 | Current report (8-K) | Viking Therapeutics, Inc. (VKTX): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/29/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/29/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/29/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.